Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024
Year: 2024
Type: article
Abstract: BackgroundWithin the International Health Regulations framework, the French High Council for Public Health was mandated in 2022 by health authorities to establish a list of priority infectious diseases for public health, surveillance and research in mainland and overseas France.AimOur objective was to establish this list.MethodsA multi-criteria decision analysis was used, as recommended by the European Centre for Disease Prevention and Control. A list of 95 entities (infectious diseases or groups of these, including the World Health Organization (WHO)-labelled 'Disease X') was established by 17 infectious disease experts. Ten criteria were defined to score entities: incidence rate, case fatality rate, potential for emergence and spread, impact on the individual, on society, on socially vulnerable groups, on the healthcare system, and need for new preventive tools, new curative therapies, and surveillance. Each criterion was assigned a relative weight by 77 multidisciplinary experts. For each entity, 98 physicians from various specialties rated each criterion against the entity, using a four-class Likert-type scale; the ratings were converted into numeric values with a nonlinear scale and respectively weighted to calculate the entity score.ResultsFifteen entities were ranked as high-priorities, including Disease X and 14 known pathologies (e.g. haemorrhagic fevers, various respiratory viral infections, arboviral infections, multidrug-resistant bacterial infections, invasive meningococcal and pneumococcal diseases, prion diseases, rabies, and tuberculosis).ConclusionThe priority entities agreed with those of the WHO in 2023; almost all were currently covered by the French surveillance and alert system. Repeating this analysis periodically would keep the list updated.
Source: Eurosurveillance
Authors: Dominique Ploin, Mathilde Alexandre, Bruno Ventelou, Didier Che, Bruno Coignard, Nathalie Boulanger, Christophe Burucoa, François Caron, Pierre Gallian, Yves Hansmann, Christian Lienhardt, Philippe Minodier, Henri Partouche, Matthieu Revest, Nadia Saidani, Gilles Salvat, Nicolas Vignier, Sylvie Floreani, Collaborators’ group, Sabine Henry, Bruno Pozzetto, Bruno Hoen
Institutions: Lyon 1 Université, École Normale Supérieure de Lyon, Centre National de la Recherche Scientifique, Inserm, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Virologie et Pathologies Humaines, Centre International de Recherche en Infectiologie, Aix-Marseille Université, Aix-Marseille Sciences Economiques, Santé Publique France, Hôpitaux Universitaires de Strasbourg, Pathogens Host Arthropod Vectors Interfaces, Université de Strasbourg, Université de Poitiers, Centre Hospitalier Universitaire de Poitiers, Centre Hospitalier Universitaire de Rouen, Dynamique Microbienne associée aux Infections Urinaires et Respiratoires, Université de Rouen Normandie, Université de Caen Normandie, Établissement Français du Sang, Institut de Recherche pour le Développement, Unité des Virus Emergents, Université de Montpellier, Assistance Publique Hôpitaux de Marseille, Hôpital Nord, Université Paris Cité, Centre Hospitalier Universitaire de Rennes, Bacterial RNAs & Medicine, Université de Rennes, Centre Hospitalier de Cornouaille, Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail, Université Sorbonne Paris Nord, Assistance Publique – Hôpitaux de Paris, Hôpital Avicenne, Infection, Anti-microbiens, Modélisation, Evolution, Centre Hospitalier Universitaire de Saint-Étienne, Université Jean Monnet, Université Jean Monnet, Interdisciplinarité en Santé Publique Interventions et Instruments de mesure complexes – Région Est, Université de Lorraine
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4405376686